Archive for 2014

eIACUC II electronic submission system goes live early December

The IACUC team has been working hard to create a new, remodeled electronic protocol submissions system for animal researchers. This new system will include: Simplified protocol form Reduced redundancy Procedure-focused, selectable standard procedures This system has been in the works over the past year, and we have made sure to test it at every stage. To date, we have logged more than 300 hours of testing. In preparation for deployment of the system, we have … Read More

TTBD aims to bring together inventors, investors and industry

The OHSU Technology Transfer & Business Development (TTBD) office is trying to send a clear message: We’ve got some really cool inventions at OHSU, and we’re open for business. Two new articles from the Portland Business Journal have focused on the TTBD office and the importance of commercializing innovations coming out of universities. The first article titled “OHSU conferences aim to bring together inventors, investors and industry,” discussed the office’s efforts to give investors and industry … Read More

Internal applications for Mary Kay Cancer Research Award due Dec. 19

The purpose of the Mary Kay Ash Foundation Innovative/Translational Cancer Research Award is to fund research in ovarian, uterine, breast, or cervical cancer. Translational research is broadly defined as research that will provide a scientific link between laboratory research and the clinic. Ultimately, the Foundation hopes that such research will lead to improvement in diagnosis, prognosis, prevention, or treatment of cancer. The Foundation anticipates funding between ten and fifteen grants. Internal deadline: December 19, 2014 … Read More

Gootee/Moda Health endowed lecture on leadership, Nov. 14

Chris McGowan, president and CEO of the Portland Trail Blazers, is giving the annual Robert G. Gootee/Moda Health Endowed Lecture in leadership and professionalism, titled “What it takes to win: Strategy and leadership.” The lecture is part of OHSU’s Professionalism Week, and is sponsored by the School of Dentistry. Friday, Nov. 14, 4 p.m. CLSB, PSU Auditorium Reception to follow This lecture is the first fully endowed lectureship in the history of the OHSU School of … Read More

Knight Cancer Institute trio to lecture on future of biomedical research, Nov. 11

Joe Gray, Ph.D., associate director of translational research for the Knight Cancer Institute and director of the Center for Spatial Systems Biomedicine, will join Knight Cancer Institute researcher Summer Gibbs, Ph.D., assistant professor in the department of biomedical engineering, and Joseph Carroll, Ph.D., director of business development for the Knight Cancer Institute, to discuss how multi-institution, public-private partnerships are being developed and how they are advancing the research of complex biological systems. Tuesday, Nov. 11 7:30 p.m.  … Read More

Clinical Research Coordinator Network (CRCN) meeting, Nov. 12

You’re invited to the next Clinical Research Coordinator Network meeting to learn about OHSU’s research pharmacy services. CRCN’s mission is to provide ongoing education and professional development activities for clinical research personnel at OHSU and the Portland VA. Meeting Topic: Everything you wanted to know about OHSU Research Pharmacy Services but were afraid to ask Wednesday, Nov. 12, 2014 11 a.m to 12 p.m. CHH 3171, room 1A Jen Petrolati, PharmD, BCPS, OHSU pharmacist in … Read More

Science on the set: New video highlights research at OHSU

Just who are the scientists of OHSU? A newly released video shows us they are innovators, groundbreakers, and pioneers. They embrace an entrepreneurial spirit and work together in a state-of-the-art scientific environment. They are bold. They are creative. They care. These extraordinary individuals are the behind-the-scenes brilliance of OHSU. In just 2 ½ minutes, the video not only shares OHSU’s scientific backstory but highlights the forward-thinking, collaborative environment that makes this a world-class place for … Read More

New method improves gene therapy outcomes

A new study recently published in Nature identifies a method for site-specific gene addition that may reduce adverse effects and lead to safe and more effective gene targeting. The study, conducted by researchers at Stanford and UCSF, was performed on mice with hemophilia B and demonstrated reduced bleeding in the mice and minimal side effects typically associated with other gene addition methods.

New, free software simplifies cell tracking

Recent advances in imaging technology allow researchers to capture snapshots of embryonic cells as they divide and migrate through development. But capturing an image of a growing embryo every 30 seconds or so, produces terabytes of data that is time consuming to analyze. A team led by HHMI, Janelia Group Leader, Philipp Keller, Ph.D., has created a piece of software that identifies and tracks dividing cells as quickly as high-speed microscopes can collect the images. … Read More

Neurotherapeutics course offered in Washington, D.C., Feb. 18-21, 2015

The National Institute of Neurological Disorders and Stroke are offering a 3 1/2 day course designed to introduce researchers to the principles of neurotherapeutic drug discovery and development, including the identification of a lead compound and IND enabling studies. The course will also address the unique challenges inherent in developing treatments for nervous system disorders and will address the particular challenges that academic neuroscientists are likely to face in planning and conducting drug discovery research. … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives